SCHEMBL1587763

SCHEMBL1587763

COC(=O)c1ccc(C(=O)NCc2ccco2)s1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.67
HPGD P15428 6/20 0.67
HSD17B10 Q99714 4/20 0.59
HTT P42858 3/20 0.59
TSHR P16473 2/20 0.59
POLB P06746 6/20 0.58
TDP1 Q9NUW8 4/20 0.58
L3MBTL1 Q9Y468 3/20 0.58
MEN1 O00255 1/20 0.58
APEX1 P27695 1/20 0.58
RECQL P46063 1/20 0.58
BLM P54132 1/20 0.58
KMT2A Q03164 1/20 0.58
KDM4E B2RXH2 3/20 0.55
MAPK1 P28482 2/20 0.55
MAPT P10636 2/20 0.55
ESR1 P03372 1/20 0.55
ESR2 Q92731 1/20 0.55
TP53 P04637 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8573181 0.91 TDP1 (0.57) ALDH1A1HPGDHSD17B10HTTPOLB
SCHEMBL1587639 0.85 HPGD (0.72) ALDH1A1HPGDHSD17B10HTTTSHR
SCHEMBL12124265 0.83 ALDH1A1 (0.71) ALDH1A1HPGDHSD17B10HTTTSHR
SCHEMBL12313818 0.82 HPGD (0.69) ALDH1A1HPGDHSD17B10HTTTSHR
SCHEMBL12265887 0.80 ALDH1A1 (0.66) ALDH1A1HPGDHSD17B10HTTTSHR
SCHEMBL1587102 0.77 HDAC1 (0.43) ALDH1A1HPGDTSHRL3MBTL1MAPK1
SCHEMBL8573184 0.76 HPGD (0.60) ALDH1A1HPGDHSD17B10HTTTSHR
SCHEMBL1587490 0.75 SMN1; SMN2 (0.42) ALDH1A1HPGDHSD17B10HTTTSHR
SCHEMBL15259140 0.75 HPGD (0.59) ALDH1A1HPGDHSD17B10HTTTSHR
SCHEMBL16011515 0.75 HDAC1 (0.61) ALDH1A1HPGDTSHRPOLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968542-B2 Thiophene compounds and thrombopoietin receptor activators NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-06-28 US disclosed
US-20110092496-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-04-21 US disclosed
US-20090118500-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD (JP) 2009-05-07 US disclosed
EP-1904472-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS Nissan Chemical Industries, Ltd. (JP) 2008-04-02 EP disclosed
WO-2007010954-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2007-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118500-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS TEK, MPL, THPO ALDH1A1 2481/4885HPGD 2277/4885HSD17B10 4151/4885
US-20110092496-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS TEK, MPL, THPO ALDH1A1 2481/4885HPGD 2277/4885HSD17B10 4151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.